Zobrazeno 1 - 10
of 386
pro vyhledávání: '"Thibaud Damy"'
Prognostic mortality factors in advanced light chain cardiac amyloidosis: A prospective cohort study
Autor:
Amira Zaroui, Mounira Kharoubi, Romain Gounot, Silvia Oghina, Charlotte Degoutte, Melanie Bezard, Arnault Galat, Soulef Guendouz, Louise Roulin, Vincent Audard, Vincent Leroy, Emmanuel Teiger, Elsa Poullot, Valérie Molinier‐Frenkel, Fabien Le Bras, Karim Belhadj, Jean‐Philippe Bastard, Soraya Fellahi, Jason Shourick, Francois Lemonier, Thibaud Damy
Publikováno v:
ESC Heart Failure, Vol 11, Iss 3, Pp 1707-1719 (2024)
Abstract Aims Predicting mortality in severe AL cardiac amyloidosis is challenging due to elevated biomarker levels and limited thresholds for stratifying severe cardiac damage. Methods and results This prospective, observational, cohort study includ
Externí odkaz:
https://doaj.org/article/4489b3e559bd42f39fe6942bd5d6b2af
Autor:
Damien Logeart, Maxime Doublet, Margaux Gouysse, Thibaud Damy, Richard Isnard, François Roubille
Publikováno v:
ESC Heart Failure, Vol 11, Iss 3, Pp 1688-1697 (2024)
Abstract Aims The use of large medical or healthcare claims databases is very useful for population‐based studies on the burden of heart failure (HF). Clinical characteristics and management of HF patients differ according to categories of left ven
Externí odkaz:
https://doaj.org/article/7c71fd25cb99420fb193c353d5bd320a
Autor:
Mohamed‐Salah Annabi, Rasmus Carter‐Storch, Amira Zaroui, Arnault Galat, Silvia Oghina, Mounira Kharoubi, Mélanie Bezard, Geneviève Derumeaux, Pascale Fanen, François Lemonnier, Elsa Poullot, Emmanuel Itti, Romain Gallet, Emmanuel Teiger, Philippe Pibarot, Thibaud Damy, Marie‐Annick Clavel
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 13 (2024)
Background Cardiac amyloidosis (CA) is frequently found in older patients with aortic stenosis (AS). However, the prevalence of AS among patients with CA is unknown. The objective was to study the prevalence and prognostic impact of AS among patients
Externí odkaz:
https://doaj.org/article/336167ce5599455cbaa367e7c56c2ad4
Autor:
Thibaud Damy, Guillaume Bourel, Michel Slama, Vincent Algalarrondo, Olivier Lairez, Pauline Fournier, Jérôme Costa, Françoise Pelcot, Agnès Farrugia, Isabelle Durand Zaleski, Hervé Lilliu, Caroline Rault, Mathilde Bartoli, Stéphane Fievez, Anna Granghaud, Jeremie Rudant, Agathe Coste, Charlotte Noirot Cosson, Pierre-Alexandre Squara, Marion Narbeburu, Bertrand De Neuville, Philippe Charron
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 18, Iss 1, Pp 1-9 (2023)
Abstract Background Precise data about ATTR-CM incidence rates at national level are scarce. Consequently, this study aimed to estimate the annual incidence and survival of transthyretin amyloid cardiomyopathy (ATTR-CM) in France between 2011 and 201
Externí odkaz:
https://doaj.org/article/6947c5f5497e43788cf4bba80c998e29
Autor:
Philippe Maury, Kevin Sanchis, Kamila Djouadi, Eve Cariou, Hubert Delasnerie, Serge Boveda, Pauline Fournier, Romain Itier, Pierre Mondoly, Quentin Voglimacci-Stephanopoli, Maxime Beneyto, Tarvinder S Dhanjal, Anne Rollin, Thibaud Damy, Olivier Lairez, Nicolas Lellouche
Publikováno v:
PLoS ONE, Vol 19, Iss 4, p e0301753 (2024)
BackgroundAtrial arrhythmias (AA) commonly affect patients with cardiac amyloidosis (CA) and are a contributing risk factor for the development of heart failure (HF). This study sought to investigate the long-term efficacy and impact of catheter abla
Externí odkaz:
https://doaj.org/article/aed673fc218e451fa4d6eaf80bcaaf51
Autor:
Emmanuelle Berthelot, Amaury Broussier, Luc Hittinger, Cristiano Donadio, Xavier Rovani, Emmanuel Salengro, Richard Megbemado, Christian Godreuil, Joel Belmin, Jean Philippe David, Bastien Genet, Thibaud Damy, FINC‐94 Network
Publikováno v:
ESC Heart Failure, Vol 10, Iss 3, Pp 2042-2050 (2023)
Abstract Aims Cardiac amyloidosis (CA) is an under‐diagnosed cause of heart failure (HF) and has a worse prognosis than other forms of HF. The frequency of death or rehospitalization following discharge for acute heart failure (AHF) in CA (relative
Externí odkaz:
https://doaj.org/article/bd19842a16b44a87a1caa1e3a3437b99
Autor:
Dania Mohty, Mohamed H. Omer, Omar Ahmad, Islam Alayary, Talal Alzahrani, Thibaud Damy, Bahaa Fadel
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
Externí odkaz:
https://doaj.org/article/1bf4c29969cc44c28a39df0c2b0f0330
Autor:
Lucia Ponti, Kristen Hsu, Thibaud Damy, Eduardo Villacorta, Nicolas Verheyen, Denis Keohane, Ronnie Wang, Monica Ines, Nisith Kumar, Carmen Munteanu, Francesco Cappelli
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundThe humanistic burden of transthyretin amyloid cardiomyopathy (ATTR-CM) is poorly defined.MethodsAn international study to comprehensively characterize the burden of ATTR-CM on patients naïve to disease-modifying therapy and their unpaid p
Externí odkaz:
https://doaj.org/article/7e479730405942a2bcadd78d24bdd5df
Autor:
Martin Nicol, Giuseppe Vergaro, Thibaud Damy, Mounira Kharoubi, Mathilde Baudet, Elena Sofia Canuti, Alberto Aimo, Vincenzo Castiglione, Michele Emdin, Bruno Royer, Stephanie Harel, Alain Cohen-Solal, Bertrand Arnulf, Damien Logeart
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundBoth light-chain (AL) amyloidosis and transthyretin (ATTR) amyloidosis are types of cardiac amyloidosis (CA) that require accurate prognostic stratification to plan therapeutic strategies and follow-ups. Cardiac biomarkers, e.g., N-terminal
Externí odkaz:
https://doaj.org/article/0c2ecf823f6948a9bcf078da4dd4045a
Autor:
Aldo P. Maggioni, Andrew L. Clark, Vivencio Barrios, Thibaud Damy, Jaroslaw Drozdz, Candida Fonseca, Lars H. Lund, Stefanie Kalus, Philippe C. Ferber, Rizwan I. Hussain, Cornelia Koch, Uwe Zeymer, the ARIADNE investigators
Publikováno v:
ESC Heart Failure, Vol 9, Iss 6, Pp 4209-4218 (2022)
Abstract Aims ARIADNE aimed to assess the association between effects of sacubitril/valsartan and no sacubitril/valsartan treatment and clinical characteristics, functional capacity, and clinical outcomes (cause‐specific mortality and hospitalizati
Externí odkaz:
https://doaj.org/article/1e95d61631394164bb9aeae759fd023a